Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions
Public ClinicalTrials.gov record NCT02421679. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Open-Label, Multicenter, Extension Study To TNX-CY-P201 To Evaluate The Safety And Efficacy Of TNX-102 SL Taken Daily At Bedtime In Patients With Military-Related PTSD And Related Conditions
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 12-week, multicenter, open-label extension study to evaluate the safety and efficacy of TNX-102 SL tablet taken daily at bedtime in patients with Military-Related PTSD or related condition. Patients recruited into this trial are those who have successfully completed the double-blind study, TNX-CY-P201 (AtEase Study) \[NCT02277704\]. Patients will not be made aware of the therapy they received during the double-blind study.
Study identification
- NCT ID
- NCT02421679
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 159 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2015 (Actual)
- Primary completion
- May 26, 2016 (Actual)
- Completion
- May 26, 2016 (Actual)
- Last update posted
- Feb 6, 2025
2015 – 2016
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tuscaloosa VA Medical Center | Tuscaloosa | Alabama | 35404 | — |
| Noesis Pharma | Phoenix | Arizona | 85032 | — |
| Sun Valley Research Center | Imperial | California | 92251 | — |
| Synergy Clinical Research | National City | California | 91950 | — |
| Excell Research, Inc | Oceanside | California | 92506 | — |
| Neuropsychiatric Research Center of Orange County | Orange | California | 92868 | — |
| CITRIALS | Riverside | California | 92506 | — |
| CESAMH | San Diego | California | 92103 | — |
| Cns, Inc. | Torrance | California | 90502 | — |
| Sarkis Clinical Trials | Lake City | Florida | 32025 | — |
| Compass Research North, LLC | Leesburg | Florida | 34748 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| Atlanta Center For Medical Research | Atlanta | Georgia | 30308 | — |
| Great Lakes Clinical Trials | Chicago | Illinois | 60640 | — |
| Novex Clinical Research | New Bedford | Massachusetts | 02740 | — |
| Premier Psychiatric Research Institute, Inc. | Lincoln | Nebraska | 68526 | — |
| Altea Research | Las Vegas | Nevada | 89102 | — |
| Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45219 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Clinical Trials of Texas | San Antonio | Texas | 78229 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02421679, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2025 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02421679 live on ClinicalTrials.gov.